What may seem like a technical exercise in global health bureaucracy- the World Health Organization’s update to its Essential ...

Nupur Lalvani says the inclusion of rapid-acting insulin analogues and GLP-1 receptor agonists in the WHO list of essential medicines will reduce out-of-pocket costs for diabetes care.

WHO has added semaglutide-used in Ozempic-to its 2025 Essential Medicines List, aiming to expand global access to key ...

The World Health Organisation’s (WHO) has announced the inclusion of rapid-acting insulin analogues and GLP-1 receptor ...

The CDSCO's expert panel consented for firm's proposal for discontinuation of products noting that alternative therapies are ...

Adherence to an app-based insulin dosing guide was associated with improved self-measured blood glucose among patients with type 2 diabetes.

DETROIT – Despite advances in insulin therapy and automated delivery systems, people with Type 1 diabetes (T1D) still face a daily struggle: manually dosing insulin before meals. Current insulin ...

A study published in Pregnancy suggests that inhaled technosphere insulin may be a safe alternative to rapid-acting insulin analogs for diabetes management during pregnancy. Cases demonstrated ...

PETERSBURG, Va., Aug. 7, 2025 /PRNewswire/ -- Governor Glenn Youngkin joined Civica officials at the company's Petersburg manufacturing facility to announce a $3 million grant from the Commonwealth of ...

Kirsty 100units/mL is supplied as a 3 mL single-patient-use prefilled pen as well as a 10 mL multiple-dose vial. The approval of insulin aspart-xjhz was supported by a comprehensive data package that ...

BRIDGEWATER, N.J., United States and BENGALURU, Karnataka, India, July 15, 2025 (GLOBE NEWSWIRE) -- Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon ...